Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

Folic acid and risk of prostate cancer: results from a randomized clinical trial.

Figueiredo JC, Grau MV, Haile RW, Sandler RS, Summers RW, Bresalier RS, Burke CA, McKeown-Eyssen GE, Baron JA.

J Natl Cancer Inst. 2009 Mar 18;101(6):432-5. doi: 10.1093/jnci/djp019.

2.

Folic acid for the prevention of colorectal adenomas: a randomized clinical trial.

Cole BF, Baron JA, Sandler RS, Haile RW, Ahnen DJ, Bresalier RS, McKeown-Eyssen G, Summers RW, Rothstein RI, Burke CA, Snover DC, Church TR, Allen JI, Robertson DJ, Beck GJ, Bond JH, Byers T, Mandel JS, Mott LA, Pearson LH, Barry EL, Rees JR, Marcon N, Saibil F, Ueland PM, Greenberg ER; Polyp Prevention Study Group..

JAMA. 2007 Jun 6;297(21):2351-9.

PMID:
17551129
3.

Chemoprevention of colorectal cancer: systematic review and economic evaluation.

Cooper K, Squires H, Carroll C, Papaioannou D, Booth A, Logan RF, Maguire C, Hind D, Tappenden P.

Health Technol Assess. 2010 Jun;14(32):1-206. doi: 10.3310/hta14320. Review.

4.

Vitamins B2, B6, and B12 and risk of new colorectal adenomas in a randomized trial of aspirin use and folic acid supplementation.

Figueiredo JC, Levine AJ, Grau MV, Midttun O, Ueland PM, Ahnen DJ, Barry EL, Tsang S, Munroe D, Ali I, Haile RW, Sandler RS, Baron JA.

Cancer Epidemiol Biomarkers Prev. 2008 Aug;17(8):2136-45. doi: 10.1158/1055-9965.EPI-07-2895.

5.

Folic acid prevents the initial occurrence of sporadic colorectal adenoma in Chinese older than 50 years of age: a randomized clinical trial.

Gao QY, Chen HM, Chen YX, Wang YC, Wang ZH, Tang JT, Ge ZZ, Chen XY, Sheng JQ, Fang DC, Yu CG, Zheng P, Fang JY.

Cancer Prev Res (Phila). 2013 Jul;6(7):744-52. doi: 10.1158/1940-6207.CAPR-13-0013.

6.

Baseline plasma total homocysteine and adenoma recurrence: results from a double blind randomized clinical trial of aspirin and folate supplementation.

Levine AJ, Grau MV, Mott LA, Ueland PM, Baron JA.

Cancer Epidemiol Biomarkers Prev. 2010 Oct;19(10):2541-8. doi: 10.1158/1055-9965.EPI-10-0536.

7.

Colorectal adenomas in a randomized folate trial: the role of baseline dietary and circulating folate levels.

Figueiredo JC, Levine AJ, Grau MV, Barry EL, Ueland PM, Ahnen DJ, Byers T, Bresalier RS, Summers RW, Bond J, McKeown-Eyssen GE, Sandler RS, Haile RW, Baron JA.

Cancer Epidemiol Biomarkers Prev. 2008 Oct;17(10):2625-31. doi: 10.1158/1055-9965.EPI-08-0382.

8.

Cancer incidence and mortality after treatment with folic acid and vitamin B12.

Ebbing M, Bønaa KH, Nygård O, Arnesen E, Ueland PM, Nordrehaug JE, Rasmussen K, Njølstad I, Refsum H, Nilsen DW, Tverdal A, Meyer K, Vollset SE.

JAMA. 2009 Nov 18;302(19):2119-26. doi: 10.1001/jama.2009.1622.

PMID:
19920236
9.

Aspirin and folic acid for the prevention of recurrent colorectal adenomas.

Logan RF, Grainge MJ, Shepherd VC, Armitage NC, Muir KR; ukCAP Trial Group..

Gastroenterology. 2008 Jan;134(1):29-38.

PMID:
18022173
10.

A randomized trial on folic acid supplementation and risk of recurrent colorectal adenoma.

Wu K, Platz EA, Willett WC, Fuchs CS, Selhub J, Rosner BA, Hunter DJ, Giovannucci E.

Am J Clin Nutr. 2009 Dec;90(6):1623-31. doi: 10.3945/ajcn.2009.28319.

11.

Interaction of calcium supplementation and nonsteroidal anti-inflammatory drugs and the risk of colorectal adenomas.

Grau MV, Baron JA, Barry EL, Sandler RS, Haile RW, Mandel JS, Cole BF.

Cancer Epidemiol Biomarkers Prev. 2005 Oct;14(10):2353-8.

12.

Folic acid supplementation inhibits recurrence of colorectal adenomas: a randomized chemoprevention trial.

Jaszewski R, Misra S, Tobi M, Ullah N, Naumoff JA, Kucuk O, Levi E, Axelrod BN, Patel BB, Majumdar AP.

World J Gastroenterol. 2008 Jul 28;14(28):4492-8.

13.

Folic acid and prevention of colorectal adenomas.

Chae YK, Yun JH.

JAMA. 2007 Sep 26;298(12):1397; author reply 1397. No abstract available.

PMID:
17895454
14.

Effect of combined folic acid, vitamin B(6), and vitamin B(12) on colorectal adenoma.

Song Y, Manson JE, Lee IM, Cook NR, Paul L, Selhub J, Giovannucci E, Zhang SM.

J Natl Cancer Inst. 2012 Oct 17;104(20):1562-75. doi: 10.1093/jnci/djs370.

15.

Dietary factors of one-carbon metabolism and prostate cancer risk.

Weinstein SJ, Stolzenberg-Solomon R, Pietinen P, Taylor PR, Virtamo J, Albanes D.

Am J Clin Nutr. 2006 Oct;84(4):929-35.

16.

Folate intake and risk of colorectal cancer and adenoma: modification by time.

Lee JE, Willett WC, Fuchs CS, Smith-Warner SA, Wu K, Ma J, Giovannucci E.

Am J Clin Nutr. 2011 Apr;93(4):817-25. doi: 10.3945/ajcn.110.007781.

17.

A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer.

Sandler RS, Halabi S, Baron JA, Budinger S, Paskett E, Keresztes R, Petrelli N, Pipas JM, Karp DD, Loprinzi CL, Steinbach G, Schilsky R.

N Engl J Med. 2003 Mar 6;348(10):883-90. Erratum in: N Engl J Med. 2003 May 8;348(19):1939.

19.

Nonsteroidal anti-inflammatory drug use after 3 years of aspirin use and colorectal adenoma risk: observational follow-up of a randomized study.

Grau MV, Sandler RS, McKeown-Eyssen G, Bresalier RS, Haile RW, Barry EL, Ahnen DJ, Gui J, Summers RW, Baron JA.

J Natl Cancer Inst. 2009 Feb 18;101(4):267-76. doi: 10.1093/jnci/djn484.

20.

Aspirin for the chemoprevention of colorectal adenomas: meta-analysis of the randomized trials.

Cole BF, Logan RF, Halabi S, Benamouzig R, Sandler RS, Grainge MJ, Chaussade S, Baron JA.

J Natl Cancer Inst. 2009 Feb 18;101(4):256-66. doi: 10.1093/jnci/djn485.

PMID:
19211452

Supplemental Content

Support Center